Iowa Multistate Pharmacy Jurisprudence Examination (MPJE) Practice Exam

Zolpidem is classified as a Schedule IV controlled substance under the Controlled Substances Act. This classification is given to medications that have a lower potential for abuse compared to substances in schedules I, II, and III, but still carry the risk of dependence and have recognized medical uses.

Zolpidem is primarily prescribed for the treatment of insomnia. It works by enhancing the activity of neurotransmitters in the brain, promoting sleep, which makes it effective for short-term management of sleep disorders. The classification as a Schedule IV substance indicates that while it has therapeutic value, it also requires careful prescription and monitoring to prevent potential misuse and dependency.

Recognizing the scheduling of medications is crucial for understanding their legal status and the regulatory measures that govern their prescription and dispensation in pharmacy practice.